Trials / Completed
CompletedNCT00171743
Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients
Switch From Tacrolimus to Cyclosporine Microemulsion: Immunosuppressive Agents and Diabetes Management in Liver Transplant Recipients in Maintenance (DIALIVER)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to determine whether the switch from tacrolimus to cyclosporine microemulsion benefits post-transplant diabetes management (in terms of glycogenic control and insulin dosage) in stable liver transplant recipients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cyclosporine microemulsion |
Timeline
- Start date
- 2004-04-01
- Primary completion
- 2006-01-01
- Completion
- 2006-01-01
- First posted
- 2005-09-15
- Last updated
- 2017-06-07
Source: ClinicalTrials.gov record NCT00171743. Inclusion in this directory is not an endorsement.